Literature DB >> 14992972

Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis.

Bjørn Rishovd Rund1, Ingrid Melle, Svein Friis, Tor K Larsen, Liv Jaeger Midbøe, Stein Opjordsmoen, Erik Simonsen, Per Vaglum, Thomas McGlashan.   

Abstract

OBJECTIVE: The authors examined the relationship of neurocognitive function with duration of untreated psychosis, premorbid illness factors, and clinical symptoms to determine whether long duration of untreated psychosis independently compromises cognitive function.
METHOD: Patients recruited to a study of the effect of an early detection program on the duration of untreated first-episode psychosis in two catchment areas were compared to patients in a similar treatment program in two other catchment areas without an early detection program. The median duration of untreated psychosis was 10.5 weeks for all patients. A total of 301 patients entered the study, and 207 completed a comprehensive neuropsychological test battery that assessed working memory/fluency, executive function, verbal learning, impulsivity, and motor speed. The median time from start of treatment to neuropsychological testing was 108 days; all patients were tested within 9 months.
RESULTS: No significant association was found between duration of untreated psychosis and any of the cognitive measures. Strong associations were demonstrated between poorer premorbid school functioning and neurocognitive deficits, especially in verbal learning and working memory. No relationship was found between neurocognitive functions and clinical measures, except for an inverse correlation of Positive and Negative Syndrome Scale negative symptoms and working memory and a positive correlation between positive symptoms and motor speed.
CONCLUSIONS: The data contribute to a disconfirmation of the hypothesis of an association between duration of untreated psychosis and neurocognitive performance at baseline.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14992972     DOI: 10.1176/appi.ajp.161.3.466

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  31 in total

1.  Disorganization and reality distortion in schizophrenia: a meta-analysis of the relationship between positive symptoms and neurocognitive deficits.

Authors:  Joseph Ventura; April D Thames; Rachel C Wood; Lisa H Guzik; Gerhard S Hellemann
Journal:  Schizophr Res       Date:  2010-06-25       Impact factor: 4.939

2.  Neurocognitive functioning in patients with first-episode schizophrenia : results of a prospective 5-year follow-up study.

Authors:  Margot Albus; Werner Hubmann; Fritz Mohr; Susanne Hecht; Petra Hinterberger-Weber; Nichi-Niels Seitz; Helmut Küchenhoff
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-10-09       Impact factor: 5.270

Review 3.  Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

4.  Neurocognitive decline in early-onset schizophrenia compared with ADHD and normal controls: evidence from a 13-year follow-up study.

Authors:  Merete Øie; Kjetil Sundet; Bjørn Rishovd Rund
Journal:  Schizophr Bull       Date:  2008-09-18       Impact factor: 9.306

Review 5.  Is active psychosis neurotoxic?

Authors:  T H McGlashan
Journal:  Schizophr Bull       Date:  2006-08-16       Impact factor: 9.306

Review 6.  Medication-free research in early episode schizophrenia: evidence of long-term harm?

Authors:  John R Bola
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

Review 7.  Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?

Authors:  Nadia Solowij; Patricia T Michie
Journal:  J Psychiatry Neurosci       Date:  2007-01       Impact factor: 6.186

8.  Cognitive Impairment in Never-Medicated Individuals on the Schizophrenia Spectrum.

Authors:  Rodolfo Solís-Vivanco; Felipe Rangel-Hassey; Pablo León-Ortiz; Alejandra Mondragón-Maya; Francisco Reyes-Madrigal; Camilo de la Fuente-Sandoval
Journal:  JAMA Psychiatry       Date:  2020-05-01       Impact factor: 21.596

9.  Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis.

Authors:  Joseph Ventura; Gerhard S Hellemann; April D Thames; Vanessa Koellner; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2009-07-22       Impact factor: 4.939

10.  Lack of an inverse relationship between duration of untreated psychosis and cognitive function in first episode schizophrenia.

Authors:  Terry E Goldberg; Katherine E Burdick; Joanne McCormack; Barbara Napolitano; Raman C Patel; Serge M Sevy; Robert Goldman; Todd Lencz; Anil K Malhotra; John M Kane; Delbert G Robinson
Journal:  Schizophr Res       Date:  2008-11-29       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.